| Literature DB >> 33440141 |
Charles Arber1, Christopher Lovejoy2, Lachlan Harris3, Nanet Willumsen4, Argyro Alatza2, Jackie M Casey2, Georgie Lines2, Caoimhe Kerins2, Anika K Mueller2, Henrik Zetterberg5, John Hardy6, Natalie S Ryan6, Nick C Fox6, Tammaryn Lashley4, Selina Wray7.
Abstract
Mutations in presenilin 1 (PSEN1) or presenilin 2 (PSEN2), the catalytic subunit of γ-secretase, cause familial Alzheimer's disease (fAD). We hypothesized that mutations in PSEN1 reduce Notch signaling and alter neurogenesis. Expression data from developmental and adult neurogenesis show relative enrichment of Notch and γ-secretase expression in stem cells, whereas expression of APP and β-secretase is enriched in neurons. We observe premature neurogenesis in fAD iPSCs harboring PSEN1 mutations using two orthogonal systems: cortical differentiation in 2D and cerebral organoid generation in 3D. This is partly driven by reduced Notch signaling. We extend these studies to adult hippocampal neurogenesis in mutation-confirmed postmortem tissue. fAD cases show mutation-specific effects and a trend toward reduced abundance of newborn neurons, supporting a premature aging phenotype. Altogether, these results support altered neurogenesis as a result of fAD mutations and suggest that neural stem cell biology is affected in aging and disease.Entities:
Keywords: Alzheimer’s disease; NOTCH; PSEN1; hippocampus; iPSC; neurogenesis; organoid; γ-secretase
Mesh:
Substances:
Year: 2021 PMID: 33440141 PMCID: PMC7809623 DOI: 10.1016/j.celrep.2020.108615
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423